Beneficial effects of pentoxifylline treatment of experimental acute pancreatitis in rats

Research in Experimental Medicine

Volumn 197, Issue 5, 1997, Pages 293-299

  Marton, J ^a   Farkas, G ^a   Takacs, T ^a   Nagy, Z ^a   Szasz, Z ^a   Varga, J ^a   Jarmay, K ^a   Balogh, A ^a   Lonovics, J ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Experimental acute pancreatitis; Interleukin 6; Pentoxifylline; Tumor necrosis factor

Indexed keywords

AMYLASE; CYTOKINE; INTERLEUKIN 6; PENTOXIFYLLINE; PERIPHERAL VASODILATING AGENT; TAUROCHOLIC ACID; TUMOR NECROSIS FACTOR;

ACUTE HEMORRHAGIC PANCREATITIS; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031938811     PISSN: 03009130     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004330050078     Document Type: Article

References (19)

1. Aho HJ, Koskensalo SM-L, Nevalainen TJ (1980) Experimental pancreatitis in the rat. Sodium taurocholate-induced acute haemorrhagic pancreatitis. Scand J Gastroenterol 15:411-416
2. Arden LA, de Groot ER, Shaap OL (1987) Production of hybridoma growth factor by human monocytes. Eur J Immunology 17:1411-1416
3. Ceska M, Birath K, Brown B (1969) A new and rapid method for the clinical determination of amylase activities in human serum and urine. Clin Chem Acta 26: 437-444
4. Doherty GM, Christian Jensen J, Alexander R, et al (1991) Pentoxifylline suppression of tumor necrosis factor gene transcription. Surgery 110:192-198
5. Espevik T, Niessen-Meyer JA (1986) A highly sensitive cell line WEHI 164 for measuring cytotoxic factor/tumor necrosis factor. J Immunol Methods 95:99-105
6. Exley AR, Leese T, Holliday MP (1992) Endotoxaemia and serum tumor necrosis factor us prognostic markers in severe acute pancreatitis. Gut 33:1126-1128
7. Farkas Gy, Mandi Y, Marton J (1996) Modification of cytokine production in septic condition following necrotizing pancreatitis. In: Papastamatiou L (ed) European I. H. P. B. A. Congress Athens '95. Monduzzi Editore, Bologna, pp 609-613
8. Grewal HP, Koth M, Mohey El Din A (1994) Induction of tumor necrosis factor in severe acute pancreatitis and its subsequent reduction after hepatic passage. Surgery 115:213-221
9. Gross V, Lese H-G, Heinisch A (1993) Inflammatory mediators and cytokines - new aspects of the pathophysiology and assessment of severity of acute pancreatitis? Hepato-Gastroenterol 40:522-530
10. Heath DI, Cruickshank A, Gudgeon M (1993) Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 34:41-45
11. Hughes CB, Grewal HP, Gaber LW (1996) Anti-TNF α therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis in the rat. Am J Surg. 171:274-280
12. McKay C, Gallagher G, Baxter JN (1994) Systemic complications in acute pancreatitis are associated with increased monocyte cytokine release. Gut 35:A574-576
13. Norman JG, Franz M, Fink GS (1995) Decreased mortality of severe acute pancreatitis after proximal cytokine blockade. Ann Surg. 221:625-634
14. Norman J, Franz M, Messina J (1995) Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery 117:648-655
15. Rinderknecht H (1994) Genetic determinants of mortality in acute necrotizing pancreatitis. Int J Pancreatol 16:11-15
16. Samlaska CP, Winfield EA (1994) Pentoxifylline (clinical review). J Am Acad Dermatol 30:603-621
17. Takacs T, Jr, Farkas G, Czako L, Jarmay K, Mandi Y, Lonovics J (1996) Time-course changes in serum cytokine levels in two experimental acute pancreatitis models in rats. Res Exp Med 196:153-161
18. Viedma JA, Perz-Mateo M, Dominguez JE (1992) Role of interleukin-6 in acute pancreatitis. Comparison wit C-reactive protein and phospholipase A. Gut 33:1264-1267
19. Windsor JA, Fearon KCH, Ross JA (1993) Role of serum endotoxin and antiendotoxin core antibody levels in predicting the development of multiple organ failure in acute pancreatitis. Br J Surg 80:1042-1046